Add Company
Join Now

Abzena Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Abzena's estimated annual revenue is currently $83.2M per year.(i)
  • Abzena's estimated revenue per employee is $155,000

Employee Data

  • Abzena has 537 Employees.(i)
  • Abzena grew their employee count by -10% last year.

Abzena's People

NameTitleEmail/Phone
1
VP, DevelopmentReveal Email/Phone
2
SVP & Global Head QualityReveal Email/Phone
3
SVP Project ManagementReveal Email/Phone
4
VP Business DevelopmentReveal Email/Phone
5
SVP, Global Business Development and StrategyReveal Email/Phone
6
VP, Business DevelopmentReveal Email/Phone
7
VP Design & DevelopmentReveal Email/Phone
8
VP Cell Line DevelopmentReveal Email/Phone
9
VP, Business DevelopmentReveal Email/Phone
10
VP Commercial StrategyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Abzena?

Abzena is a life sciences group with its headquarters in the UK and two sites in the US. Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and ADC drug development services in the pharmaceutical industry. Working with companies and academic groups all over the world, including most of the top 20 biopharmaceutical companies, Abzena supports the development and manufacture of better treatments for patients. Multiple antibodies which have been created using Abzena’s technologies are currently being progressed through clinical development by our licensees.

keywords:N/A

N/A

Total Funding

537

Number of Employees

$83.2M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Abzena News

2022-04-20 - Abzena, planning new Sanford facility, raises $65M to bolster ...

Abzena is expected to add the jobs over five years and to invest $213 million into the facility by the end of 2025, according to an executive...

2022-04-13 - Abzena nabs $65M to bolster manufacturing and research ...

Roughly one year after dropping designs on a $200 million biologics plant in North Carolina, antibody-drug conjugate specialist Abzena has...

2022-03-30 - Abzena secures $65m to expand production capacity ...

Abzena, a global CDMO specializing in the integrated development and manufacture of complex biologics and bioconjugates, has secured $65M in...

2021-01-12 - Abzena plots 6th bi­o­log­ics plant as de­mand for mam­malian cell-line pro­duc­tion con­tin­ues to grow

With de­mand for bi­o­log­ics man­u­fac­tur­ing at an all-time high, UK CD­MO Abzena has rushed to add a big­ger foot­print to keep up. Now look­ing to ex­pand its US pres­ence, Abzena will tack on an­oth­er man­u­fac­tur­ing site — its third state­side. Abzena said the ex­pan­sion, which will ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$241.4M5479%N/A
#2
$157.2M5540%N/A
#3
$127.1M5919%N/A
#4
$186.7M5957%N/A
#5
$209.9M6228%N/A